Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.

Saved in:
Bibliographic Details
Title: Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.
Authors: Appleton JP; Stroke, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Applied Health Research, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK., Woodhouse LJ; Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK., Anderson CS; Faculty of Medicine, The George Institute for Global Health, Sydney, New South Wales, Australia.; The George Institute China at Peking University Health Science Center, Beijing, China.; Neurology, Royal Prince Alfred Hospital, Sydney Health Partners, Sydney, New South Wales, Australia., Ankolekar S; Department of Neurology, King's College Hospital NHS Foundation Trust, London, UK., Cala L; Faculty of Health and Medical Sciences, University of Western Australia, Crawley, Western Australia, Australia., Dixon M; Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.; East Midlands Ambulance Service NHS Trust, Nottingham, UK., England TJ; Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK., Krishnan K; Stroke, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Mair G; Centre for Clinical Brain Sciences, Dementia Research Institute, Univeristy of Edinburgh, Edinburgh, UK., Muir KW; Institute of Neurology and Psychology, University of Glasgow, Glasgow, UK., Potter J; Bob Champion Research and Education Building, University of East Anglia, Norwich, UK., Price CI; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK., Randall M; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Robinson TG; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Roffe C; Stroke Research in Stoke, Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK., Sandset EC; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Research and Development, Norwegian Air Ambulance Foundation, Oslo, Norway., Saver JL; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Shone A; Research and Graduate Services, University of Nottingham, Nottingham, UK., Siriwardena AN; East Midlands Ambulance Service NHS Trust, Nottingham, UK.; Community and Health Research Unit, University of Lincoln, Lincoln, UK., Wardlaw JM; Centre for Clinical Brain Sciences, Dementia Research Institute, Univeristy of Edinburgh, Edinburgh, UK., Sprigg N; Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.; Stroke, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Bath PM; Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK philip.bath@nottingham.ac.uk.; Stroke, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Corporate Authors: RIGHT-2 Investigators
Source: Stroke and vascular neurology [Stroke Vasc Neurol] 2024 Feb 27; Vol. 9 (1), pp. 38-49. Date of Electronic Publication: 2024 Feb 27.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101689996 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-8696 (Electronic) Linking ISSN: 20598688 NLM ISO Abbreviation: Stroke Vasc Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-8696
DOI:10.1136/svn-2022-001634